NHS
UK Report Provides Guidance on Use of AI in Genomic Health Prediction
A new report outlined several recommendations for responsibly rolling out AI-informed genomic health prediction tools through the National Health Service in the UK.
BMJ Report Reveals UK Officials' Concerns Over Grail Test Effectiveness, Trial Design
The report also mentions a US investor class action lawsuit that alleges Illumina and Grail officials oversold Galleri's potential.
UK NHS Declines to Accelerate Grail Galleri Implementation Following Early Data Review
The decision comes just weeks after Grail officials touted the decision as a potential positive catalyst for the firm as it prepares to be divested by Illumina.
UK's NICE Expands Tumor Profiling Recommendations for Guiding Adjuvant Chemo in Early Breast Cancer
Previously, NICE recommended EndoPredict, Prosigna, and Oncotype DX for node-negative breast cancer only, but the new guidance includes lymph node-positive disease.
Encouraged by results from a pilot project, Guy's and St Thomas' NHS Foundation Trust researchers are expanding their evaluation program to more sites across the UK.